Injectable Extended-Release Buprenorphine (XR-B) in a Correctional Setting: Qualitative Interviews

Launched by LIFESPAN · Apr 4, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at a new way to treat people with opioid use disorder (OUD) who are currently incarcerated, using a medication called extended-release buprenorphine (XR-B). Unlike traditional treatments that require daily doses, XR-B is given as an injection once a month, which may make it easier for individuals to stick with their treatment while in prison. The study aims to understand how effective this method could be and which groups of inmates might benefit the most from it. To gather information, researchers will conduct in-depth interviews with incarcerated individuals and key staff members from the Rhode Island Department of Corrections who are involved in addiction treatment programs.

To participate in this trial, individuals must be over 18 years old, speak English, and have a diagnosis of opioid use disorder. However, those with severe mental health issues are not eligible, as they require special care. Participants can expect to share their experiences and opinions about the medication and the treatment process, helping researchers learn more about how to improve care for individuals with OUD in correctional settings. The trial is currently recruiting participants, and anyone interested should check if they meet the eligibility criteria.

Gender

ALL

Eligibility criteria

• Incarcerated individuals, inclusion criteria:
• • English speaking
• • Over the age of 18
• • Diagnosed with opioid use disorder
• Incarcerated individuals, Exclusion Criteria:
• • - Diagnosed with "Severe, Persistent, Mental Illness (SPMI)" Rationale for Exclusion: These individuals suffer from severe mental health disease and therefore warrant greater protection, have greater risk for coercion, and offer insights to severe co-diagnosis treatment that, while important, remain outside the scope of general MAT implementation.
• Organizational Stakeholders, Inclusion Criteria:
• • - Employed or contracted by Rhode Island Department of Corrections (for organizational staff interviews) and involved with the Medication for Addiction Treatment (MAT) program
• Organizational Stakeholders, Exclusion Criteria:
• • - If not permitted by their organizational union to participate